470 related articles for article (PubMed ID: 28667794)
21. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model.
Huang TY; Chu HC; Lin YL; Ho WH; Hou HS; Chao YC; Liao CL
Biochem Biophys Res Commun; 2009 Nov; 389(4):634-9. PubMed ID: 19765544
[TBL] [Abstract][Full Text] [Related]
22. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
[TBL] [Abstract][Full Text] [Related]
23. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging.
Chang CT; Ho TY; Lin H; Liang JA; Huang HC; Li CC; Lo HY; Wu SL; Huang YF; Hsiang CY
PLoS One; 2012; 7(3):e31808. PubMed ID: 22412841
[TBL] [Abstract][Full Text] [Related]
24. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
Yoneda J; Nishikawa S; Kurihara S
BMC Cancer; 2021 Dec; 21(1):1343. PubMed ID: 34922485
[TBL] [Abstract][Full Text] [Related]
25. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
[TBL] [Abstract][Full Text] [Related]
26. Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositis.
Renck D; Santos AA; Machado P; Petersen GO; Lopes TG; Santos DS; Campos MM; Basso LA
Invest New Drugs; 2014 Dec; 32(6):1301-7. PubMed ID: 25052233
[TBL] [Abstract][Full Text] [Related]
27. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
[TBL] [Abstract][Full Text] [Related]
28. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
[TBL] [Abstract][Full Text] [Related]
29. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters.
Mitsuhashi H; Suemaru K; Li B; Cui R; Araki H
Eur J Pharmacol; 2006 Dec; 551(1-3):152-5. PubMed ID: 17046745
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model.
Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
Biomed Pharmacother; 2011 Aug; 65(5):339-44. PubMed ID: 21723691
[TBL] [Abstract][Full Text] [Related]
32. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
[TBL] [Abstract][Full Text] [Related]
33. Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats.
Mi H; Dong Y; Zhang B; Wang H; Peter CCK; Gao P; Fu H; Gao Y
Cell Physiol Biochem; 2017; 42(6):2330-2341. PubMed ID: 28848081
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy mediates intestinal injury via p53/p53 upregulated modulator of apoptosis (PUMA) signaling pathway.
Zhan YS; Tan SW; Mao W; Jiang J; Liu HL; Wu B
J Dig Dis; 2014 Aug; 15(8):425-34. PubMed ID: 24814616
[TBL] [Abstract][Full Text] [Related]
35. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.
Ohkawara T; Takeda H; Kato K; Miyashita K; Kato M; Iwanaga T; Asaka M
Scand J Gastroenterol; 2005 Nov; 40(11):1321-7. PubMed ID: 16334442
[TBL] [Abstract][Full Text] [Related]
36. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM
Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363
[TBL] [Abstract][Full Text] [Related]
37. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
[TBL] [Abstract][Full Text] [Related]
38. Effects of polaprezinc on gastric mucosal damage and neurotransmitters in a rat model of chemotherapy-induced vomiting.
Liu ZY; Xie WB; Ru Li M; Teng N; Liang X; Zhang ZQ
J Int Med Res; 2018 Jun; 46(6):2436-2444. PubMed ID: 29756515
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury.
Omatsu T; Naito Y; Handa O; Mizushima K; Hayashi N; Qin Y; Harusato A; Hirata I; Kishimoto E; Okada H; Uchiyama K; Ishikawa T; Takagi T; Yagi N; Kokura S; Ichikawa H; Yoshikawa T
J Gastroenterol; 2010 Jul; 45(7):692-702. PubMed ID: 20174833
[TBL] [Abstract][Full Text] [Related]
40. Ginger extract and polaprezinc exert gastroprotective actions by anti-oxidant and growth factor modulating effects in rats.
Ko JK; Leung CC
J Gastroenterol Hepatol; 2010 Dec; 25(12):1861-8. PubMed ID: 21091998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
